MTBVAC is a candidate vaccine against tuberculosis in humans currently in research trials. It is based on a genetically modified form of the Mycobacterium tuberculosis pathogen isolated from humans.[1]
^Martin C (2020). "Update on TB Vaccine Pipeline". Applied Sciences. 10 (7): 2632. doi:10.3390/app10072632.
MTBVAC is a candidate vaccine against tuberculosis in humans currently in research trials. It is based on a genetically modified form of the Mycobacterium...
showed promise in animal tests in 2003 and phase I human trials in 2008. MTBVAC, an attenuated form of Myobacterium tuberculosis. Phase II trials were completed...